Clinical Trial Update: Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bortezomib in combination chemotherapy for relapsed acute lymphoblastic leukemia or lymphoblastic lymphoma in children and young adults…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2017-01-27